Should I buy Cintas (CTAS) stock or is it too late?
⭐ The most reliable of them, either direction: Truist Securities — 81% of its targets hit on this sector (210 calls tested). It aims for $230 (+11 %), call made on September 25, 2026, maturing on September 25, 2027 (19 d ago).
Firm-by-firm track record on Cintas
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| RBC Capital | 100 % | +34.0 % | 16 | $206 +0% |
| Baird | 90 % | +30.7 % | 10 | $222 +8% |
| JP Morgan | 88 % | +19.6 % | 8 | $230 +11% |
| Truist Securities | 75 % | +18.4 % | 8 | $230 +11% |
| Citigroup | 88 % | +13.7 % | 8 | $181 -12% |
| UBS | 71 % | +7.9 % | 7 | $235 +14% |
| B of A Securities | 43 % | +5.4 % | 7 | $230 +11% |
| Goldman Sachs | 62 % | +3.1 % | 8 | $257 +25% |
✅ Reasons to believe
- 75% of analysts rate it a buy (Buy consensus, 8 ratings) — a sign of market conviction.
- Median price target $230, i.e. +11% from the current price ($206).
- 6 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
⚠️ Reasons to hesitate
- Even the most reliable firm on CTAS, RBC Capital (100% hit rate, 16 scored calls), only targets $206 (call made on September 24, 2026, maturing on September 24, 2027) (+0%) in its most recent call, and $206 (call made on December 19, 2025, maturing on December 19, 2026) (+0%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 8 ratings, 1 is neutral and 1 is a sell.
- High valuation (P/E ~41): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on CTAS
Median target $230 (+11%) · 8 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Cintas now?
We won't decide for you. The facts: 75% of analysts rate it a buy, median target $230 (+11%), and RBC Capital (most reliable on CTAS, 100%) targets $206. Weigh that against valuation (P/E ~41). This is not personalized advice.
Is it too late to invest in Cintas?
Not according to analysts: the median target ($230) is still +11% above the current price ($206) (most reliable on CTAS: RBC Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Cintas still worth investing in?
It depends on the gap between the price ($206) and its estimated value: analysts target $230 on median (+11%), with 75% buys (most reliable on CTAS: RBC Capital, 100%). Cross-check with their real reliability on CTAS and the cautions above. Information, not advice.
What's the main risk in buying CTAS?
Even the most reliable firm on CTAS, RBC Capital (100% hit rate, 16 scored calls), only targets $206 (call made on September 24, 2026, maturing on September 24, 2027) (+0%) in its most recent call, and $206 (call made on December 19, 2025, maturing on December 19, 2026) (+0%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Cintas profile (consensus, analyst reliability, price target, performance).